Application of nanotechnology in bladder cancer diagnosis and therapeutic drug delivery

H Li, J Zhu, G Weng, J Li, L Li, J Zhao - Journal of Materials Chemistry …, 2023 - pubs.rsc.org
Bladder cancer (BC) is one of the most common malignant tumors in the urinary system, and
its high recurrence rate causes a great economic burden to patients. Traditional diagnosis …

[HTML][HTML] Mechanistic review of sulforaphane as a chemoprotective agent in bladder cancer

GE Kennelley, T Amaye-Obu, BA Foster… - American Journal of …, 2023 - ncbi.nlm.nih.gov
Regular consumption of cruciferous vegetables has numerous health benefits, including
reduced cancer risk and improved patient outcomes. Sulforaphane (SFN) is an …

Urinary Analysis of FGFR3 and TERT Gene Mutations Enhances Performance of Cxbladder Tests and Improves Patient Risk Stratification

Y Lotan, JD Raman, B Konety… - The Journal of …, 2023 - auajournals.org
Purpose: Cxbladder tests are urinary biomarker tests for detection of urothelial carcinoma.
We developed enhanced Cxbladder tests that incorporate DNA analysis of 6 single …

Human epidermal growth factor receptor 2 in non-muscle invasive bladder cancer: issues in assessment methods and its role as prognostic/predictive marker and …

F Sanguedolce, D Russo, V Mancini… - Urologia …, 2019 - karger.com
Although human epidermal growth factor receptor 2 (HER2) plays a prognostic and
predictive role in breast and gastric cancer, its function in bladder cancer (BC) is still …

Urinary microbiome evaluation in patients presenting with hematuria with a focus on exposure to tobacco smoke

M Moynihan, T Sullivan, K Provenzano… - … and Reports in …, 2019 - Taylor & Francis
Purpose To better characterize the urinary microbiome in males and contribute to overall
understanding of the urinary microbiota specifically in patients undergoing evaluation for …

[PDF][PDF] Research Progress in Bladder Cancer Diagnosis and Therapy

X Chen, X Tan, F Fan, C Li - Cancer Plus, 2021 - scholar.archive.org
Bladder cancer is one of the most frequent malignancies associated with high morbidity,
high mortality, as well as inconvenient post-operative recurrence. Typical symptoms of …

Differences in the Molecular Characteristics of Bladder Cancer between Smokers and Nonsmokers

MO Hoque - European Urology Focus, 2018 - eu-focus.europeanurology.com
Bladder cancer (BC) is the ninth most common cancer worldwide, with an estimated 430 000
new cases in 2012, and on average is three to four times more common in men than in …